OPKO Health, Inc.: OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth ...
ots13m
EQS-News: Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals
Disposal/Strategic Company Decision Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals 28.02.2025 / 10:20 CET/CEST The issuer is solely ...
Les Echos Patrimoine2m
Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals
Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées sur les bourses de Paris, Bruxelles, Amsterdam, Lisbonne, Francfort et New York.